Dwight d Koeberl, MD, PhD
Duke University
3
3
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Priya Kishnani
Duke University
Shared therapeutic areas:
Worked with same sponsors:
Paolo Banfi, MD
IRCCS Fondazione Don Carlo Gnocchi
Shared therapeutic areas:
Regina Trollmann, MD
University Hospital Erlangen
Shared therapeutic areas:
Benedikt Schoser, MD
Friedrich-Baur-Institute, Dep. of Neurology Klinikum der Universitaet Muenchen Munich, Germany
Shared therapeutic areas:
Barry J. Byrne, MD, PhD
University of Florida
Shared therapeutic areas:
Irina Kline, MD
Amicus Therapeutics
Shared therapeutic areas:
Isabel Illa, MD pHD
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Shared therapeutic areas:
Ozlem Goker-Alpan, MD
O&O Alpan
Shared therapeutic areas:
whu-Liang Hwu, MD, PhD
National Taiwan University Hospital
Shared therapeutic areas:
Barry J Byrne, MD, PhD
University of Florida
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Albuterol in Individuals With Late Onset Pompe Disease (LOPD)
Safety and Efficacy of Albuterol in Individuals With Late-onset Pompe Disease
Safety and Efficacy of Clenbuterol in Individuals With Late-onset Pompe Disease and Receiving Enzyme Replacement Therapy
All 3 trials loaded